A trial to learn if different doses of REGN17092 are safe in healthy adults

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-505041-52-00

Acronym

R17092-HV-2312

Enrollment

128

Registered

2023-08-16

Start date

2023-11-28

Completion date

2025-03-04

Last updated

2024-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SARS-CoV-2 (COVID-19)

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Belgium

None listed

Source: EU CTIS · Data processed: Feb 4, 2026